CISATRACURIUM HIKMA 2 mg/ml, solution for injection/for infusion 5 ampoules of 10 ml
Active ingredients: BÉSILATE DE CISATRACURIUM, CISATRACURIUM
Commercialized according to BDPMDispensing in France: Prescription only, hospital use
Solution for injection or infusion5 ampoules of 10 mlintraveineuse
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- CISATRACURIUM HIKMA 2 mg/mL, solution injectable/pour perfusion
- Pharmaceutical form
- solution injectable ou pour perfusion
- Route of administration
- intraveineuse
- Presentation description
- 5 ampoule(s) en verre de 10 ml
- Marketing authorisation holder
- HIKMA FARMACEUTICA (PORTUGAL)
- Reimbursement according to BDPM
- —
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 24 Jan 2025
- Prescription and dispensing conditions
- Prescription only, hospital use
- List I: prescription-only medicine
- Hospital use only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69823420CIP75510252CIP133400955102526Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CISATRACURIUMsolution | 2,00 mg · 1 mL de solution | FT |
| BÉSILATE DE CISATRACURIUMsolution | 2,68 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Other packages of this medicine
The same medicine in another pack size, according to BDPM.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
Group of similar medicines: BESILATE DE CISATRACURIUM équivalant à CISATRACURIUM 2 mg/ml - NIMBEX 2 mg/ml, solution injectable/pour perfusion